These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33483619)

  • 21. [Molecular Mechanism and Malignant Clonal Evolution of Multiple Myeloma].
    Ding F; Zhu P; Wu XQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1513-6. PubMed ID: 26524068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in clonal evolution of multiple myeloma].
    Wang Y; An G; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):611-615. PubMed ID: 34455753
    [No Abstract]   [Full Text] [Related]  

  • 23. Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma.
    Binder M; Rajkumar SV; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Hwa YL; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kyle RA; Kumar SK
    Blood Cancer J; 2016 Mar; 6(3):e401. PubMed ID: 26967818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
    Heider M; Nickel K; Högner M; Bassermann F
    Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment.
    Hultcrantz M; Rustad EH; Yellapantula V; Arcila M; Ho C; Syed MH; Papaemmanuil E; Zhang Y; Maura F; Landgren O
    Blood Cancer J; 2020 Jul; 10(7):76. PubMed ID: 32699232
    [No Abstract]   [Full Text] [Related]  

  • 26. Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition.
    Raab MS; Lehners N; Xu J; Ho AD; Schirmacher P; Goldschmidt H; Andrulis M
    Blood; 2016 Apr; 127(17):2155-7. PubMed ID: 26884375
    [No Abstract]   [Full Text] [Related]  

  • 27. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.
    Misund K; Hofste Op Bruinink D; Coward E; Hoogenboezem RM; Rustad EH; Sanders MA; Rye M; Sponaas AM; van der Holt B; Zweegman S; Hovig E; Meza-Zepeda LA; Sundan A; Myklebost O; Sonneveld P; Waage A
    Leukemia; 2022 Jul; 36(7):1887-1897. PubMed ID: 35643867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
    Guo G; Raje NS; Seifer C; Kloeber J; Isenhart R; Ha G; Yee AJ; O'Donnell EK; Tai YT; Richardson PG; Bianchi G; Laubach JP; Warren D; Gemme E; Voisine J; Frede J; Kokkalis A; Yun H; Dimitrova V; Vijaykumar T; Meyerson M; Munshi NC; Anderson KC; Knoechel B; Lohr JG
    Leukemia; 2018 Aug; 32(8):1838-1841. PubMed ID: 29749395
    [No Abstract]   [Full Text] [Related]  

  • 29. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation.
    Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ
    Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming.
    Liang Y; He H; Wang W; Wang H; Mo S; Fu R; Liu X; Song Q; Xia Z; Wang L
    Mol Cancer; 2022 Sep; 21(1):182. PubMed ID: 36131282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies.
    Nanaji NM; Chen QC; Singh Z; Ross DD; Elman AH; Zou YS
    Leuk Lymphoma; 2015; 56(8):2470-2. PubMed ID: 25586604
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.
    Walker BA; Wardell CP; Melchor L; Hulkki S; Potter NE; Johnson DC; Fenwick K; Kozarewa I; Gonzalez D; Lord CJ; Ashworth A; Davies FE; Morgan GJ
    Blood; 2012 Aug; 120(5):1077-86. PubMed ID: 22573403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.
    Melchor L; Brioli A; Wardell CP; Murison A; Potter NE; Kaiser MF; Fryer RA; Johnson DC; Begum DB; Hulkki Wilson S; Vijayaraghavan G; Titley I; Cavo M; Davies FE; Walker BA; Morgan GJ
    Leukemia; 2014 Aug; 28(8):1705-15. PubMed ID: 24480973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrosome amplification and clonal evolution in multiple myeloma: Short review.
    Kryukova E; Kryukov F; Hajek R
    Crit Rev Oncol Hematol; 2016 Feb; 98():116-21. PubMed ID: 26589397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetic architecture of multiple myeloma.
    Morgan GJ; Walker BA; Davies FE
    Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.
    Puig N; Conde I; Jiménez C; Sarasquete ME; Balanzategui A; Alcoceba M; Quintero J; Chillón MC; Sebastián E; Corral R; Marín L; Gutiérrez NC; Mateos MV; González-Díaz M; San-Miguel JF; García-Sanz R
    Leukemia; 2015 Jun; 29(6):1435-7. PubMed ID: 25567133
    [No Abstract]   [Full Text] [Related]  

  • 37. Clonal evolution in myeloma: a narrow road to remission.
    Miething CC
    Haematologica; 2019 Jul; 104(7):1292-1293. PubMed ID: 31257204
    [No Abstract]   [Full Text] [Related]  

  • 38. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
    Weinhold N; Ashby C; Rasche L; Chavan SS; Stein C; Stephens OW; Tytarenko R; Bauer MA; Meissner T; Deshpande S; Patel PH; Buzder T; Molnar G; Peterson EA; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Tian E; Epstein J; Barlogie B; Davies FE; Heuck CJ; Walker BA; Morgan GJ
    Blood; 2016 Sep; 128(13):1735-44. PubMed ID: 27516441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal evolution of one rare case of multiple myeloma with bilateral testicular mass as initial presentation.
    Lin N; Wu Y; Liang Y; Mo W; Li Y; Zhang R
    Ann Hematol; 2020 Feb; 99(2):377-378. PubMed ID: 31879789
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiregion Sequence Analysis to Predict Intratumor Heterogeneity and Clonal Evolution.
    Ahn S; Huang H
    Methods Mol Biol; 2021; 2243():283-296. PubMed ID: 33606263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.